GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 92 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $823,747 | -30.5% | 296,312 | -13.7% | 0.01% | -37.5% |
| Q4 2022 | $1,184,551 | -60.1% | 343,348 | -70.3% | 0.01% | -65.2% |
| Q3 2022 | $2,972,000 | +413.3% | 1,156,264 | +383.4% | 0.02% | +475.0% |
| Q2 2022 | $579,000 | -17.6% | 239,174 | +40.2% | 0.00% | -20.0% |
| Q1 2022 | $703,000 | -39.1% | 170,623 | +90.0% | 0.01% | -37.5% |
| Q4 2021 | $1,155,000 | +19.1% | 89,805 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $970,000 | +16.9% | 89,805 | -1.2% | 0.01% | +16.7% |
| Q2 2021 | $830,000 | -2.0% | 90,891 | +1.2% | 0.01% | -14.3% |
| Q1 2021 | $847,000 | +43.8% | 89,805 | -40.0% | 0.01% | +40.0% |
| Q4 2020 | $589,000 | +40.9% | 149,565 | -5.3% | 0.01% | +25.0% |
| Q3 2020 | $418,000 | +186.3% | 157,860 | +617.1% | 0.00% | +100.0% |
| Q2 2020 | $146,000 | – | 22,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |